The estimated Net Worth of John William Wulf is at least 1.69 百万$ dollars as of 15 March 2023. John Wulf owns over 80,000 units of agilon health, inc stock worth over 652,888$ and over the last 4 years John sold AGL stock worth over 1,033,044$.
Sign up
John Wulf AGL stock SEC Form 4 insiders trading
John has made over 3 trades of the agilon health, inc stock since 2021, according to the Form 4 filled with the SEC. Most recently John exercised 80,000 units of AGL stock worth 360,000$ on 15 March 2023.
The largest trade John's ever made was exercising 80,000 units of agilon health, inc stock on 15 March 2023 worth over 360,000$. On average, John trades about 18,021 units every 78 days since 2021. As of 15 March 2023 John still owns at least 203,392 units of agilon health, inc stock.
You can see the complete history of John Wulf stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's John Wulf's mailing address?
John's mailing address filed with the SEC is C/O AGILON HEALTH, INC., 6210 E HWY 290, SUITE 450, AUSTIN, TX, 78723.
Insiders trading at agilon health, inc
Over the last 4 years, insiders at agilon health, inc have traded over 2,766,210,380$ worth of agilon health, inc stock and bought 408,814 units worth 1,411,859$ . The most active insiders traders include Investment Associates Ix, L...、Veeral Desai、Benjamin Shaker. On average, agilon health, inc executives and independent directors trade stock every 12 days with the average trade being worth of 4,807,999$. The most recent stock trade was executed by Benjamin Kornitzer on 14 March 2024, trading 5,434 units of AGL stock currently worth 17,443$.
What does agilon health, inc's logo look like?
Complete history of John Wulf stock trades at agilon health, inc
agilon health, inc executives and stock owners
agilon health, inc executives and other stock owners filed with the SEC include:
-
Steven Jackson Sell,
Pres, CEO & Director -
Dr. Benjamin Kornitzer M.D.,
Chief Medical & Quality Officer -
Mat Varghese,
Chief People Officer -
Ben Shaker,
Chief Markets Officer -
Claire Mulhearn,
Chief Communications & Public Affairs Officer -
Lisa Ali,
Chief Compliance Officer -
Lyn Amor Macaraeg,
VP of Legal Services -
Matthew Dale Gillmor CFA,
VP of Investor Relations -
Girish Venkatachaliah,
Chief Technology Officer -
Timothy S. Bensley,
Chief Financial Officer -
Silvana Battaglia,
Director -
Timothy Bensley,
Chief Financial Officer -
Joan Danieley,
Chief Administrative Officer -
Theodore Halkias,
Chief Business Officer -
Michelle A Gourdine,
Director -
Veeral Desai,
Chief Strategy & Dev. Officer -
Lisa Dombro,
Exper. & Innovation Officer -
Clay Richards,
Director -
Sharad Mansukani,
Director -
Benjamin Kornitzer,
Chief Med. & Quality Officer -
Benjamin Shaker,
Chief Markets Officer -
Ronald A Williams,
Director -
Glenn Sobotka,
Chief Accounting Officer -
Girish Venkatachaliah,
Chief Technology Officer -
John William Wulf,
Director -
Michael L Smith,
Director -
Karen Mc Loughlin,
Director -
Richard J Schnall,
Director -
Investment Associates Ix, L...,
-
Steven Sell,
CEO & President -
Jeffrey A. Schwaneke,
Chief Financial Officer -
Diana Mckenzie,
Director -
Priscilla Kasenchak,
Chief Accounting Officer -
Timothy Gertsch,
Chief Accounting Officer